Comment on "study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration" by Santovena et al. [Int. J. Pharm. 477 (2014) 32-38].
Dr Falk Pharma GmbH, Leinenweberstraße 5, 79041 Freiburg, Germany. Electronic address: martin.moerike@drfalkpharma.de.
Martin
M
Mörike
D005079:Excipients / Q000737:chemistry*; D005990:Glycerol / Q000737:chemistry*; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
D005079:Excipients; D014580:Ursodeoxycholic Acid; D005990:Glycerol